Indução da carcinogênese mamária experimental em ratas com 7,12-dimetilbenz(a)antraceno by Barros, Alfredo Carlos S. D. et al.
257
REV. HOSP. CLÍN. FAC. MED. S. PAULO 59(5):257-261, 2004
From the Discipline of Gynecology, Hospital
das Clínicas, Faculty of Medicine, University
of São Paulo – São Paulo/SP, Brazil.
E-mail: clinab@terra.com.br
Received for publication on
February 27, 2004.
ORIGINAL RESEARCH
INDUCTION OF EXPERIMENTAL MAMMARY
CARCINOGENESIS IN RATS WITH 7,12-
DIMETHYLBENZ(A)ANTHRACENE
Alfredo Carlos S. D. Barros, Elisa Naomi K. Muranaka, Lincon Jo Mori, Christina
Helena T. Pelizon, Kyoshi Iriya, Giovana Giocondo and José Aristodemo Pinotti
BARROS ACSD et al. Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)anthracene.
Rev. Hosp. Clín. Fac. Med. S. Paulo 59(5):257-261, 2004.
PURPOSE: To test an experimental model of chemical mammary carcinogenesis induction in rats.
METHODS: Twenty young virgin Sprague-Dawley female rats, aged 47 days, received 20 mg of 7,12-
dimethylbenz(a)anthracene (DMBA) intragastrically by gavage. Afterwards, at 8 and 13 weeks, their mammary glands were
examined. At the end of the experiment, the animals were sacrificed, and the mammary tumors were measured and weighed.
Tumor fragments were analyzed using light microscopy.
RESULTS: Eight weeks after DMBA injection, 16 rats presented at least 1 breast tumor (80%). After 13 weeks, all of
them (100%) developed breast carcinomas that were confirmed by histopathological analysis.
CONCLUSION: This experimental animal model of chemical mammary induced carcinogenesis is feasible and can be
used in further experiments on the role of tumorigenic biomodulator substances.
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Breast cancer represents the most
common neoplastic disease in females,
accounting for up to one third of new
diagnoses of women’s cancer in certain
regions of the world. In developing
countries traditionally known for low
incidence of breast cancer, increases in
both incidence and mortality have
been recently detected.1
The fundamental issue in breast
cancer control is prevention (primary
and secondary), which depends on
identification of the determinants of
the disease, in terms of initiation and
promotion.
The possibility of using biomo-
dulators of breast carcinogenesis, such
as selective estrogen receptor modula-
tors (SERMS), aromatase and
cyclooxygenase inhibitors, and dietary
factors is very promising.2,3 Neverthe-
less, before clinical investigations are
conducted, all of these strategies
should be previously validated in ani-
mal models.
Mammary tumors arise spontane-
ously in a few animal species, for ex-
ample dogs, rats, and mice.4 For prac-
tical reasons most of the studies about
experimental breast carcinogenesis are
conducted with rodents.5
Mammary glands of several rat
strains, mainly Sprague-Dawley and
Wistar-Furth, are susceptible to trans-
formation induced by chemical car-
cinogens, and the 2 most widely used
active chemical inductors of mammary
carcinogenesis are 7,12-
dimethylbenz(a)anthracene (DMBA)
and N-methylnitrosurea.6,7
Based on Russo and Russo experi-
ence,8,9 we decided to test an animal
model for chemical mammary carcino-
genesis employing DMBA, given by
gavage, in young female Sprague-
Dawley rats.
The objectives of our study were to
investigate the feasibility of the model,
the percentage of rats that develop
breast cancer, the number of glands af-
fected per animal, and the histological
aspects of the induced neoplasms.
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METHODS
The group of test animals was
formed by 20 young virgin Sprague-
Dawley female rats. This type of rat lives
an average of 3 years, starting its repro-
ductive function, which lasts for about
1 year, at 50 to 60 days of age. They have
7 to 10 pregnancies during this period,
delivering 7 to10 pups each time.
Mammary gland tumors were in-
duced by a single dose of 20 mg of
DMBA diluted in soy oil (1 mL) given
intragastrically by gavage (Figure 1).
All of the rats, with an average weight
of 182.9 g (161-213 g), received the
chemical carcinogen at the age of 47
days.
The animals were bred in our labo-
ratory under ideal conditions of tem-
perature, humidity, and light, and they
were fed with appropriate ration in pel-
lets and filtered water.
We performed physical examina-
tions weekly. Each rat had 6 pairs of
mammary glands that were checked by
inspection, touching, and palpation.
For evaluation of the induction pattern
we performed 2 specific analyses at 8
and 13 weeks after drug injection.
At the age of 138 days (13 weeks
after DMBA), the animals were sacri-
ficed in a CO2 chamber. Complete au-
topsies were performed, mammary
tumors were measured and weighed,
and the findings recorded. Representa-
tive fragments of the tumors were fixed
in 10% formaldehyde and paraffin em-
bedded. The blocks were sectioned
every 5 mm, and slides were prepared
with hematoxylin-eosin stain and ex-
amined using light microscopy.
RESULTS
The first assessment 8 weeks after
DMBA administration revealed that 16
animals developed at least 1 mammary
tumor (80%), with an average of 3.0
tumors per animal (0-6).
Thirteen weeks after DMBA ad-
ministration, all of the rats (100%) de-
veloped breast tumors, with an average
of 4.9 tumors per animal (1-15). The
mean size of the tumors was 1.8 cm
(0.5-5). The weight of the tumors
ranged from 0.06 g to 29.3 g with a
mean weight of 2.4 g (Table 1).
Figure 2 shows an animal with
chemically induced breast tumors.
In 1 rat (animal 18), tumors were
formed apart from the breasts in the
neck area of the animal.
Histological examination showed
that the neoplasms were adenocarcino-
mas with several morphological types.
The most common type encountered
was adenoid cystic carcinoma, which
is characterized by sheets of tumor
cells separated by small cystic spaces
(Figure 3). Papillary carcinoma was
also very common, which consists of
proliferating epithelial cells with deli-
cate cores of connective tissue sepa-
rated by narrow spaces (Figure 4). A
smaller proportion of tumors was of the
myoepithelial type, characterized by a
myxoid appearance and resembling
mixed mammary tumors of dogs.
It is interesting to point out that,
despite the tumor malignancy, no
metastases were detected in the autop-
sies.
DISCUSSION
The mammary gland is one of the
few organs that is not totally developed
at birth. It undergoes intense evolutive
and functional modifications during
puberty, pregnancy, and lactation.
Russo and Russo10 have described the
developmental progression of human
breast tissue and listed 4 different types
of breast lobules. Type 1 (or virginal)
is the most undifferentiated lobule and
occurs in the immature female breast
Table 1 - Number of tumors per rat at 8 and 13 weeks after 7,12-dimethylbenz(a)anthracene (DMBA) administration.
ANIMAL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
8 weeks 1 1 3 1 _ 2 2 _ _ 1 4 4 7 6 2 6 1 7 _ 1
13 weeks 7 6 3 1 1 3 3 1 3 5 5 5 7 8 4 8 4 15 6 4
Figure 1 - Administration of DMBA by gavage.
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before menarche. Type 2 lobule has a
more complex morphology, being com-
posed by a higher number of ductular
structures per lobule. Type 3 has an av-
erage of 80 alveoli (ductules) and is
formed under gestational hormonal
stimulation. Type 4 is a secreting lob-
ule during lactation.
The mammary tumors in rats arise
in the epithelium of the terminal end
buds, which are comparable structures
to the terminal ductal lobular units in
the human breast.12
The degree of lobular differentia-
tion is of importance in the suscepti-
bility to carcinogenesis. Based on
studies of the pathogenesis of human
mammary cancer, it is possible to say
that the type 1 lobule is the site of ori-
gin of preneoplastic lesions. Parous
women undergo lobular differentia-
tion, whereas nulliparous women sel-
dom reach the type 3 lobule stage. The
breasts of parous women free of can-
cer have the lowest percentage of type
1 lobules.
Lobules type 1 and 2 are charac-
terized by having a shorter doubling
time than type 3, growing faster and
having a higher DNA labeling index.
The susceptibility of the mammary
gland to DMBA carcinogenesis is
strongly age-dependent, being maxi-
mal when the drug is administered to
rats between the ages of 45 and 60
days, which is the age of the begin-
ning of sexual maturity.12 Active breast
organogenesis and high rate of prolif-
eration of type 1 and 2 lobules are
characteristics of that period. The
chance of chemically inducing breast
cancer in rats is greater if DMBA is ad-
ministered in this phase of the life of
the animals. This was the reason why
we injected the drug at the age of 47
days. According to the literature, the
induced tumors are generally ductal
carcinomas or papillary carcinomas,
but it is possible that typical
fibroadenomas, adenomas, and papil-
lomas are also formed.5,11,13
Figure 2 - Breast carcinomas induced by 7,12-dimethylbenz(a)anthracene (DMBA).
Figure 4 - Papillary carcinoma (HE-40x).
Figure 3 - Adenoid cystic carcinoma (HE-200x).
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Epithelial and myoepithelial cell
proliferation were observed in most of
the induced tumors in our experiment.
Russo et al. found the same histologi-
cal aspects. They also carefully pre-
sented the correlation between
neoplastic and non-neoplastic altera-
tions in the mammary gland of rats and
in women, which was proposed in a
consensus meeting on this subject held
in Hannover, Germany, in 1987.11 Most
of the lesions found in rats have cor-
responding lesions in humans, allow-
ing the translation of basic research in
rats into the clinic.14
The induced DMBA tumors in this
study were multifocal and locally ag-
gressive, but no single case of
metastases was identified. This fact is
in agreement with studies done by
other authors, and metastasis from
even the most anaplastic induced
tumors are low in frequency.11
The absence of metastases in
chemically produced mammary neo-
plasms opens the door for speculation.
According to Murad and von Haam,13
the proliferation of epithelial and
myoepithelial cells in relatively equal
proportions may be a protective factor
against metastasis. In human breast
carcinomas, proliferation occurs al-
most exclusively in epithelial cells.
DMBA is highly lipophilic and re-
quires metabolic activation for its
carcinogenicity. Several tissues are ca-
pable of activating DMBA, and these
include the mammary gland. In the
breast, DMBA is converted to
epoxides, active metabolites with a
capacity for damaging the DNA mol-
ecule, the main event in carcinogen-
esis initiation. With the higher cellu-
lar proliferative index of types 1 and
2 lobules, there is higher metabolic ac-
tivity and more epoxide forma-
tion.15,16,17
The first DMBA-induced tumor
was observed about 5 weeks after in-
jection of the carcinogen, but indi-
vidual tumoral latency was not as-
sessed in our study. It is possible,
though, to grossly estimate tumor for-
mation patterns, since after 8 weeks,
there were tumors in 16 animals, and
after 13 weeks, tumors were detected
in all of them.
This experimental animal model
closely mimics human breast cancer
and can be used as a comparative
group in further studies with the pur-
pose of elucidating the role of
biomodulation in mammary carcino-
genesis. The effects of pretreatment
and posttreatment of rats with hor-
mones, antihormones, isoflavones,
celecoxib, and many other substances
that have action on mammary carcino-
genesis will be the endpoints of future
research in our laboratory using this
animal model.
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RESUMO
BARROS ACSD e col. Indução da
carcinogênese mamária experimen-
tal em ratas com 7,12 – dimetil-
benz(a)antraceno. Rev. Hosp. Clín.
Fac. Med. S. Paulo 59(5):257-261,
2004.
OBJETIVO: Testar um modelo ex-
perimental de indução química de
carcinogênese mamária em ratas.
MATERIAL E MÉTODOS: Com
47 dias de vida, 20 ratas Sprague-
Dawley, jovens e virgens, receberam
por gavagem intragástrica 20 mg de
7 , 1 2 - d i m e t i l b e n z ( a ) a n t r a c e n o
(DMBA). Oito e 13 semanas depois da
injeção de droga as mamas das ratas
foram examinadas. Ao final os animais
foram sacrificados e fragmentos dos
tumores foram estudados ao microscó-
pio.
RESULTADO: Oito semanas de-
pois da injeção de DMBA 16 ratas
apresentavam tumor nas mamas (80%).
Com 13 semanas todas desenvolveram
carcinomas de mama (100%), que fo-
ram confirmados por análise
histopatológica.
CONCLUSÃO: Este modelo expe-
rimental de indução química de
carcinogênese mamária é factível e
pode ser empregado em futuras pesqui-
sas para avaliar o papel de substânci-
as biomoduladoras da tumorigênese.
UNITERMOS: Câncer de mama.
Modelos animais. Carcinógenos. Tu-
mores induzidos por DMBA.
Carcinogênese mamária em ratas.
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